---
figid: PMC5813752__onco12312-fig-0003
figlink: /pmc/articles/PMC5813752/figure/onco12312-fig-0003/
number: F3
caption: 'Schema of ERBB2. (A): The G660D mutation is located in the ERBB2 transmembrane
  domain. Other missense or in‐frame mutations are also shown. The MEK/ERK signaling
  pathway is stimulated by dimerization of ERBB2. (B): Mechanisms of monoclonal antibodies,
  such as trastuzumab, and tyrosine kinase inhibitors (TKIs), such as afatinib, for
  ERBB2. Trastuzumab and other monoclonal antibodies bind to the ECD and prevent dimerization
  of ERBB2, whereas afatinib and other TKIs bind to the kinase domain (KD) and inhibit
  ERBB2. The KD is activated in ERBB2 KD‐ or TMD‐mutant tumors regardless of ECD status.Abbreviations:
  ECD, extracellular domain; ERBB2, avian erythroblastic leukemia viral oncogene homolog
  2 (erb‐b2 receptor tyrosine kinase 2); ERK, extracellular signal‐regulated kinases;
  MEK, MAPK‐ERK kinase; Mut, mutation; RAF, rapidly accelerated fibrosarcoma proto‐oncogene,
  serine/threonine kinase; RAS, rat sarcoma viral oncogene homolog; TMD, transmembrane
  domain.'
pmcid: PMC5813752
papertitle: Therapeutic Potential of Afatinib for Cancers with ERBB2 (HER2) Transmembrane
  Domain Mutations G660D and V659E.
reftext: Hiromasa Yamamoto, et al. Oncologist. 2018 Feb;23(2):150-154.
pmc_ranked_result_index: '135720'
pathway_score: 0.8708324
filename: onco12312-fig-0003.jpg
figtitle: Schema of ERBB2
year: '2018'
organisms:
- Homo sapiens
ndex: 5bb0b34e-de9d-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5813752__onco12312-fig-0003.html
  '@type': Dataset
  description: 'Schema of ERBB2. (A): The G660D mutation is located in the ERBB2 transmembrane
    domain. Other missense or in‐frame mutations are also shown. The MEK/ERK signaling
    pathway is stimulated by dimerization of ERBB2. (B): Mechanisms of monoclonal
    antibodies, such as trastuzumab, and tyrosine kinase inhibitors (TKIs), such as
    afatinib, for ERBB2. Trastuzumab and other monoclonal antibodies bind to the ECD
    and prevent dimerization of ERBB2, whereas afatinib and other TKIs bind to the
    kinase domain (KD) and inhibit ERBB2. The KD is activated in ERBB2 KD‐ or TMD‐mutant
    tumors regardless of ECD status.Abbreviations: ECD, extracellular domain; ERBB2,
    avian erythroblastic leukemia viral oncogene homolog 2 (erb‐b2 receptor tyrosine
    kinase 2); ERK, extracellular signal‐regulated kinases; MEK, MAPK‐ERK kinase;
    Mut, mutation; RAF, rapidly accelerated fibrosarcoma proto‐oncogene, serine/threonine
    kinase; RAS, rat sarcoma viral oncogene homolog; TMD, transmembrane domain.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K2
  - TTN
  - BRAF
  - MUT
  - ARAF
  - MAP2K1
  - MAPK1
  - HRAS
  - KRAS
  - RAF1
  - MAPK3
  - ECD
  - NRAS
  - ERBB2
  - 888888Y
  - Lapatinib
  - Afatinib
  - TMD
genes:
- word: MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: TMD
  symbol: TMD
  source: hgnc_alias_symbol
  hgnc_symbol: TTN
  entrez: '7273'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Muts
  symbol: MUT
  source: hgnc_symbol
  hgnc_symbol: MUT
  entrez: '4594'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ECD
  symbol: ECD
  source: hgnc_symbol
  hgnc_symbol: ECD
  entrez: '11319'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: ERBB2
  symbol: ERBB2
  source: hgnc_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
chemicals:
- word: 888888Y
  source: MESH
  identifier: D015019
- word: Lapatinib
  source: MESH
  identifier: C490728
- word: Afatinib
  source: MESH
  identifier: C522924
diseases:
- word: TMD
  source: MESH
  identifier: D049310
figid_alias: PMC5813752__F3
redirect_from: /figures/PMC5813752__F3
figtype: Figure
---
